IMI
Intermolecular, Inc.
IMI
IMI
Delisted
IMI was delisted on the 19th of September, 2019.
32 hedge funds and large institutions have $20.9M invested in Intermolecular, Inc. in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
7
Increased
6
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EM
Emancipation Management
New York
|
+$412K |
| 2 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$345K |
| 3 |
JPMorgan Chase & Co
New York
|
+$331K |
| 4 |
PCM
Prelude Capital Management
New York
|
+$159K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$158K |
Top Sellers
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$169K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$151K |
| 3 |
JFA
JNBA Financial Advisors
Bloomington,
Minnesota
|
-$19K |
| 4 |
HK
Horizon Kinetics
New York
|
-$10.8K |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
-$10.3K |
